CHARLOTTE, NC, UNITED STATES, Janairu 28, 2021 /EINPresswire.com/ - SonaCare Medical, LLC, babban mai haɓakawa kuma mai ƙera ƙarancin fasahar duban dan tayi (HIFU), yana farin cikin bayar da rahoton buga Focal Therapy Idan aka Kwatanta da Prostatectomy Radical for non-Metastatic Prostate Cancer: A Propensity Score-Matched Study (1 ) kawai aka saki a Yanayi. A cikin wannan nazarin, an kwatanta farfajiyar kulawa da ƙarancin ƙwayar prostatectomy ta amfani da nauyin 1-to-1 wanda aka dace da shi don shekara ta jiyya, shekaru, PSA, Gleason, T-Stage, tsayin daka kansar da amfani da kwayar neoadjuvant. A 3, 5 da 8 shekaru Rashin Samun Kyauta (FFS) don ƙananan ƙwayar cuta shine 86%, 82% da 79% idan aka kwatanta da 91%, 86% da 83% FFS don maganin kulawa a lokaci guda. Hakanan, na bayanin kula ƙididdigar kulawa ta biyu sunkai kusan 16% na raunin prostatectomy kuma kusan 17% don maganin mai da hankali.

Karen Cornett, Mataimakin Shugaban Harkokin Gudanar da Clinical, don SonaCare Medical, ya ce, “Wannan yanayin ya dace da nazarin kwatanta tiyata mai tsauraran ra'ayi tare da maganin kulawa, yawancin waɗanda aka bi da su tare da Sonablate HIFU, yana da mahimmanci saboda yadda yake kwatanta duka zaɓuɓɓukan maganin. Wannan kwatancen yana nuna fa'idodi na ƙananan haɗari, marasa lafiya, kulawa mai mahimmanci akan tiyata mai tsauri. Kasancewar marasa lafiyar HIFU suna wurin kiwon lafiya ne kawai na 'yan awanni kuma suna bukatar karancin ma'aikata a cikin dakin tiyata hakan ya sa ya dace musamman yanzu da muke cikin cutar COVID. "

Jagoran binciken, Farfesa Hashim Ahmed, daya daga cikin kwararrun masana kan cutar kanjamau a duniya, ya ce, “Mun san cewa kusan 1 a cikin 3 da ke da tiyata ta asali don cutar kansar mafitsara suna nadamar shawarar da suka yanke daga baya. Sau da yawa wannan yana faruwa ne saboda rashin cikakken bayani game da zaɓuɓɓukan da ke ɗaukar ƙananan tasirin tasiri. Nazarinmu ya nuna cewa maganin mai da hankali yana ɗauke da ragin kashi 10 a cikin zubewar fitsari da matsalolin jima'i. Abu mai mahimmanci, a karo na farko mun nuna cewa tana da irin wannan maganin kansa a cikin shekaru 5-8 bayan jiyya zuwa cututtukan prostatectomy. ” Ya kara da cewa, "Duk da cewa maganin kulawa bai dace da duk marasa lafiya ba, akwai dubbai a duk shekara wadanda suka dace kuma ya kamata a sanar dasu sosai game da shi."

(1) Shah, T., Reddy, D., et al. Maganin gyaran kafa idan aka kwatanta da prostatectomy mai raɗaɗi don rashin ciwon sankara ta gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen ciwo: Yanayi. 2021. https://doi.org/10.1038/s41391-020-00315-y

Tun Sonablate^® sun sami izinin FDA a ranar 9 ga Oktoba, 2015, dubunnan marasa lafiya da yawa sun sami Sonablate HIFU prostate hanya a duk wuraren 60 + a Amurka, gami da manyan cibiyoyin ilimi a California, Indiana, Oklahoma, Maryland, New York, Arizona da Texas . Fiye da likitocin Amurka 70 yanzu suna ba da HIFU ƙwayar narkewar nama ga marasa lafiya a matsayin ƙaramar cutarwa mai sauƙi ga tiyata ko radiation.

Sonablate^® yana da izinin 501 (K) a cikin Amurka kuma an nuna shi don haɓakar haɓakar duban dan tayi mai ƙarfi (HIFU) na ƙwayar prostate. Hankali: Dokar Tarayya (Amurka) ta hana wannan na'urar siyarwa ta hanyar umarnin likita.

GAME DA SONACARE MEDICAL, LLC
Likita na SonaCare shine jagorar duniya a cikin ƙananan fasahohin duban dan tayi. Likitocin SonaCare sun himmatu wajen haɓaka fasahohin da ke da nasaba da duban dan tayi wanda ke tallafawa madaidaiciyar hanyar kirkirar sabbin hanyoyin kulawa da yanayin lafiya. SonaCare Medical, tare da reshensa na Focus Surgery, Inc., suna tsarawa da ƙera na'urorin kiwon lafiya, gami da waɗannan masu zuwa: Sonablate^®, wanda ke da izinin 501 (K) a cikin Amurka; Sonablate^®500, wanda ke da alamar CE kuma ya sami izini na izini a cikin sama da ƙasashe 50 a waje da Amurka, Sonatherm^® laparoscopic HIFU tsarin cirewar tiyata, wanda ke da izinin 510 (K) a cikin Amurka, yana da CE Marking kuma ya sami izini na izini a cikin sama da ƙasashe 30 a waje da Amurka

Don ƙarin bayani, ziyarci www.SonaCareMedical.com

MAGANGANUN GABA GABA
Bayanin hangen nesa na Kamfanin ya dogara ne da tsammanin gudanarwa na yau da tsammani game da kasuwancin Kamfanin da aikinsa, tattalin arziki da sauran yanayi na gaba da hasashen abubuwan da zasu faru nan gaba, yanayi da sakamakon. Kamar yadda yake tare da kowane tsinkaye ko tsinkaya, maganganun neman gaba suna da saukin kamuwa da rashin tabbas da canje-canje a cikin yanayi. Hakikanin sakamakon Kamfanin na iya bambanta na kayan aiki daga waɗanda aka bayyana ko aka ambata a cikin bayanan sa na gaba. Duk wani bayanin da Kamfanin yayi na gaba yana magana ne kawai daga ranar da aka sanya shi. Kamfanin ba shi da wani nauyi a kansa, kuma ya bayyana duk wani takalifi akansa, sabuntawa ko canza bayanansa na gaba, ko dai sakamakon sabon bayani, abubuwan da suka biyo baya ko wasu abubuwan.

Karen Cornett
Likitocin SonaCare
+ 1 704-805-1885
imel da mu a nan

Ka kawai karanta:

Babban fifikon EIN Presswire shine bayyana gaskiya. Ba mu ba da izinin abokan cinikayya, kuma editocinmu suna ƙoƙari su yi hankali game da gusar da abubuwan ƙarya da ɓatarwa. A matsayinka na mai amfani, idan kaga wani abu da muka rasa, da fatan zaka kawo mana shi. Taimakon ku maraba. EIN Presswire, Labaran Intanet na Kowa da Kowa ™, yayi kokarin ayyana wasu iyakokin da suka dace a duniyar yau. Da fatan za a duba namu Jagororin Edita don ƙarin bayani.

ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:

Gaskiyar cewa marasa lafiya na HIFU suna cikin wurin likita ne kawai na 'yan sa'o'i kuma suna buƙatar ƙarancin kasancewar ma'aikata a cikin ɗakin aiki ya sa ya zama manufa musamman a yanzu yayin da muke tsakiyar cutar ta COVID.
A cikin shekaru 3, 5 da 8 Rashin Rayuwa Kyauta (FFS) na prostatectomy mai tsattsauran ra'ayi shine 86%, 82% da 79% idan aka kwatanta da 91%, 86% da 83% FFS don maganin mai da hankali a lokaci guda.
Tun da Sonablate® ya sami izinin FDA akan Oktoba 9, 2015, dubban marasa lafiya da yawa sun sami hanyar Prostate Sonablate HIFU a cikin wurare 60+ a cikin U.